Pharmacielo Ltd (PCLO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 276 | 324 | 100 | 557 | -113 |
| Accounts receivable | 237 | -79 | -151 | 119 | -262 |
| Other Working Capital | -2,711 | -3,506 | -647 | -712 | 7,805 |
| Other Operating Activity | -2,974 | -1,760 | -4,087 | -5,058 | -12,471 |
| Operating Cash Flow | $-5,173 | $-5,021 | $-4,785 | $-5,095 | $-5,041 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -421 | 2 | -291 | -428 | -1,630 |
| Net Acquisitions | -5 | -26 | -1,084 | -181 | -149 |
| Purchase Of Investment | N/A | N/A | N/A | -750 | 0 |
| Sale Of Investment | 0 | 0 | 0 | 777 | 0 |
| Other Investing Activity | 0 | 0 | 750 | 0 | 0 |
| Investing Cash Flow | $-426 | $-24 | $-626 | $-581 | $-1,780 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -38 | 0 | N/A | N/A | N/A |
| Debt Repayment | -74 | -75 | -77 | -82 | -14 |
| Common Stock Issued | 0 | 0 | N/A | N/A | 7,801 |
| Other Financing Activity | 5,017 | 130 | 12,505 | 903 | 4,651 |
| Financing Cash Flow | $4,904 | $56 | $12,428 | $821 | $12,438 |
| Beginning Cash Position | 6,033 | 11,022 | 4,004 | 8,860 | 3,242 |
| End Cash Position | 5,338 | 6,033 | 11,022 | 4,004 | 8,860 |
| Net Cash Flow | $-695 | $-4,989 | $7,017 | $-4,855 | $5,618 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,173 | -5,021 | -4,785 | -5,095 | -5,041 |
| Capital Expenditure | -421 | N/A | -291 | -428 | -1,630 |
| Free Cash Flow | -5,594 | -5,021 | -5,076 | -5,522 | -6,671 |